The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis

The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis

<i>Background and objectives:</i> Everolimus (EVE) is a mammalian target of the rapamycin (mTOR) inhibitor that is widely used in cancer patients. Pulmonary toxicity, usually manifesting as interstitial pneumonitis, is a serious adverse effect of this drug. Radiation therapy, which is of...

Full description

Bibliographic Details
Main Authors: Mehmet Fuat Eren, Ayfer Ay Eren, Mutlay Sayan, Birsen Yücel, Şahende Elagöz, Yıldıray Özgüven, Irina Vergalasova, Ahmet Altun, Saadettin Kılıçkap, Vasudev Daliparty, Nuran Beşe
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Medicina
Subjects:
radiation therapy
rat
everolimus
pneumonitis
pulmonary fibrosis
Online Access:https://www.mdpi.com/1010-660X/56/7/348

Internet

https://www.mdpi.com/1010-660X/56/7/348

Similar Items